Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study

The aim of the present study was to determine the efficacy and safety of intravitreal brolucizumab therapy for neovascular age-related macular degeneration (AMD) in the real-world setting. The REBA study (real-world experience with brolucizumab in wet AMD) was a retrospective, observational, multice...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilgic, Alper, Kodjikian, Laurent, March de Ribot, Francesc, Vasavada, Vaishali, Gonzalez-Cortes, Jesus H., Abukashabah, Amro, Sudhalkar, Aditya, Mathis, Thibaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268719/
https://www.ncbi.nlm.nih.gov/pubmed/34201729
http://dx.doi.org/10.3390/jcm10132758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268719/
https://www.ncbi.nlm.nih.gov/pubmed/34201729
http://dx.doi.org/10.3390/jcm10132758

Ejemplares similares